Phase I and pharmacokinetic study of E7070, a novel sulfonamide, given at a daily times five schedule in patients with solid tumors. A study by the EORTC-early clinical studies group (ECSG).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples